Our study further revealed that HB could potentiate TREG cells while suppressing other effector CD4+ T cell subsets both in vivo and in vitro, which at least partially constituted the mechanisms of HB-mediated improvement in AD. The gene discussed is CD4; the disease is Alzheimer disease.